Fundraising FoxPhantom Neuro
Austin, US · Founded 2020 · Delaware corporation · 8 known investors
Find your way into Phantom Neuro
Sign up to see every warm intro you have to Phantom Neuro
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Phantom Neuro team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Phantom Neuro develops a minimally invasive, subcutaneous muscle-computer interface that uses under-the-skin sensors and on-device AI to translate muscle signals into control commands for robotic devices. Its initial application is prosthetic limb control for people with upper and lower limb difference, with future uses in robotics and human augmentation.
Founders & leadership
Phantom Neuro was founded in 2020 by Connor Glass.
Board
Investors · 8
How we know: Breakout Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Capital Factory's portfolio page · Not right? Tell us
__Twitter.png)
How we know: LionBird's portfolio page · a partner's Signal profile · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Time BioVentures's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$15.4M disclosed across 2 rounds · 2022–2025
▶$12.1MraisedMar 2025 · 22 investors · BiotechnologyRule 506(b)
- Connor GlassExecutive Officer, Director, Promoter
- D.A. WallachDirector
- Edward MichaelDirector
- Offering amount
- $19.3M
- Amount sold
- $12.1M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$3.3MraisedMar 2022 · 6 investors · BiotechnologyRule 506(b)
- Connor GlassExecutive Officer, Director
- Robert LordDirector
- Offering amount
- $3.3M
- Amount sold
- $3.3M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Companies working in the same space as Phantom Neuro.
In the news
Frequently asked questions
- What does Phantom Neuro do?
- Phantom Neuro develops a minimally invasive, subcutaneous muscle-computer interface that uses under-the-skin sensors and on-device AI to translate muscle signals into control commands for robotic devices. Its initial application is prosthetic limb control for people with upper and lower limb difference, with future uses in robotics and human augmentation.
- Who founded Phantom Neuro?
- Phantom Neuro was founded by Connor Glass in 2020.
- Who are Phantom Neuro's investors?
- Phantom Neuro's investors include Breakout Ventures, Capital Factory, Crosscourt Ventures, Draper Associates, Gaingels, LionBird, Time BioVentures, E1 Ventures.
- How much funding has Phantom Neuro raised?
- Phantom Neuro has disclosed $15.4M raised across 2 rounds.
- Where is Phantom Neuro headquartered?
- Phantom Neuro is headquartered in Austin, US.